Posted on 8/4/20
BostonGene Announces Scientific Collaboration with Leading Cancer Center
WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene Corporation (BostonGene), a biomedical software company focused on defining optimal precision medicine-based therapies for cancer patients, today announced its collaboration with The Weinstock . . .
Posted on 8/4/20
Alegeus and HealthSherpa Partner
WALTHAM, Mass.--(BUSINESS WIRE)--Alegeus, the market leader in consumer-directed healthcare (CDH) solutions, today announced a partnership with HealthSherpa, a health technology company that has created a simplified . . .
Posted on 8/4/20
Quartet Health Partners With SilverCloud Health
NEW YORK--(BUSINESS WIRE)--Today, Quartet Health announced a partnership with SilverCloud Health to offer clinically-validated digital mental health support to its patients nationwide. Through the collaboration, patients . . .
Posted on 8/4/20
Industry Leader Gryphon Networks Named Best Call Compliance Software By G2 Crowd
Framework designed to help organizations develop and implement a robust, comprehensive digital identity strategy to address healthcare’s unique security, compliance, and workflow challengesImprivata®, the digital identity . . .
Posted on 8/4/20
Karyopharm Reports Second Quarter 2020 Financial Results and Highlights Recent Company Progress
Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the quarter ended June 30, 2020. In addition, . . .
Posted on 8/4/20
Arvinas Reports Second Quarter 2020 Financial Results and Provides Corporate Update
NEW HAVEN, Conn., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biopharmaceutical company creating a new class of drugs based on targeted . . .
Posted on 8/4/20
Cerence Announces Third Quarter 2020 Results
BURLINGTON, Mass., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today reported its third fiscal quarter 2020 results . . .
Posted on 8/4/20
IPO Update: Checkmate Pharmaceuticals Readies $75 Million IPO
SummaryCheckmate Pharmaceuticals has proposed terms for a $75 million U.S. IPO.The firm is developing treatments for melanoma and head and neck squamous cell carcinoma.CMPI has achieved . . .
Posted on 8/3/20
Applied BioMath Announces Collaboration with Verseau Therapeutics
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced their collaboration with . . .
Posted on 8/3/20
BlueCrest Capital Management Transitions to SS&C for Multi-Asset Execution Management
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced BlueCrest Capital Management has selected SS&C Eze to power its trading.SS&C Eze's EMS stood out with its advanced . . .
Posted on 8/3/20
Provident Healthcare Partners Advises Illinois Gastroenterology Institute And Central Illinois Endoscopy Center In Its Partnership With GI Alliance
Illinois Gastroenterology Institute (IGI), the second largest independent gastroenterology practice in Illinois, has partnered with GI Alliance (GIA). GIA, an entity formed through Waud Capital's partnership . . .
Posted on 8/3/20
DAS Health Acquires New England IT Company
DAS Health Ventures, Inc., an industry leader in health IT and management, announced today it completed the acquisition of Technology Seed, LLC a managed IT and . . .
Posted on 8/3/20
Rhythm Pharmaceuticals Reports Second Quarter 2020 Financial Results
BOSTON, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a late-stage biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare . . .
Posted on 8/3/20
Minerva Neurosciences Reports Second Quarter 2020 Financial Results and Business Updates
WALTHAM, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central . . .
Posted on 8/3/20
2020’s Best & Worst States for Health Care – WalletHub Study
The COVID-19 pandemic has impacted medical care in countless ways, from postponing elective surgeries to moving many visits online. To shed some light on where people . . .
Posted on 8/3/20
Checkmate Pharmaceuticals Begins IPO Process
SummaryCheckmate Pharmaceuticals has filed to raise $75 million in an IPO.The firm is developing a drug candidate for the treatment of various cancers.CMPI has shown promising . . .
Posted on 8/3/20
Thermo Fisher Long Case: Trajectory Is Clear, Buy On Value
SummaryStrong quarter exit and clear guidance for Q4 2020 on the back of $1.3 billion in COVID-19 related sales YTD.16% dividend increase and commitment to fulfil . . .
Posted on 8/3/20
Why Pfizer Could Be a Bigger Coronavirus Winner Than Moderna
There's one U.S. company developing a novel-coronavirus vaccine candidate that's probably been in the headlines more than any other. Moderna (NASDAQ:MRNA) made waves earlier this year . . .
Posted on 8/3/20
3 Reasons to Buy Moderna Now
Moderna (NASDAQ:MRNA) has taken center stage in the race to develop a coronavirus vaccine. In March, the clinical-stage biotech company became the first to bring a . . .
Posted on 8/2/20
Inozyme Pharma Closes IPO
BOSTON, July 30, 2020 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of . . .
Posted on 8/2/20
AlloVir Prices Upsized IPO
CAMBRIDGE, Mass., July 30, 2020 (GLOBE NEWSWIRE) -- AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, today announced the pricing of its upsized initial . . .
Posted on 8/2/20
Spero Therapeutics to Provide Business Update
CAMBRIDGE, Mass., July 29, 2020 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in . . .
Posted on 7/31/20
Harbour BioMed Announces Strategic Partnership with Viva Biotech
Harbour BioMed (HBM), a global clinical stage biopharmaceutical company and Viva Biotech (Shanghai) Ltd., a world-leading structure-based drug discovery platform today announced a strategic partnership under . . .
Posted on 7/31/20
Biogen - Second Quarter Highlights World Of Opportunity
SummaryBiogen had impressive second quarter results, with a single digit P/E ratio despite its growing businesses.The company submitted its BLA for its Alzheimer's drugs and has . . .
Posted on 7/31/20
1 Reason to Sell Moderna Now
There are multiple bear arguments floating around as reasons to sell Moderna (NASDAQ:MRNA), one of the drugmakers leading the way to develop a coronavirus vaccine.Most of . . .
Boston
